Diabetes and arterial disease
1Diabetes-Forschungsinstitut, Düsseldorf, FRG.
Insights
Diabetes accelerates atherosclerosis through disturbed lipid metabolism and platelet hyperactivity, increasing the risk of macrovascular disease. Further research is needed to clarify the role of metabolic control and aging in this complex relationship.
Area of Science:
- Cardiovascular Disease
- Endocrinology
- Metabolic Disorders
Background:
- Macroangiopathy (atherosclerosis) is a frequent chronic complication in diabetic patients.
- The independent role of diabetes in atherosclerosis development is not fully understood, as atherosclerosis also affects the general population.
- Potential interactions between diabetes, aging, and metabolic control influence macrovascular disease risk.
Purpose of the Study:
- To investigate the specific contribution of diabetes to the development of atherosclerosis.
- To explore the mechanisms linking diabetes to macrovascular complications.
- To examine the relationship between metabolic control and macrovascular disease in diabetic individuals.
Main Methods:
- Analysis of common risk factors for macroangiopathy in diabetic populations.
- Examination of low-density lipoprotein (LDL) metabolism disturbances in poorly controlled diabetes.
- Investigation of platelet hyperactivity and its potential role in atherosclerotic plaque development.
Main Results:
- Disturbed LDL metabolism in diabetic patients promotes foam cell and fatty streak formation.
- Platelet hyperactivity in diabetes may contribute to fibrous plaque development and vessel wall repair dysregulation.
- A diabetes-specific risk for atherosclerosis persists even after accounting for common risk factors.
Conclusions:
- Diabetes independently contributes to atherosclerosis through specific metabolic and platelet-related pathways.
- Platelet hyperactivity and the release of a diabetic serum growth factor may drive advanced plaque development.
- Understanding these diabetes-specific mechanisms is crucial for managing macrovascular risk in diabetic patients.
Abstract:
Macroangiopathy (or atherosclerosis) is a common and chronic complication in diabetic patients. Unlike other diabetic complications, atherosclerosis is not unique to diabetes, confounding analysis of its relationship with the diabetic condition. Evidence of an independent role for diabetes in the development of atherosclerosis remains equivocal. The main determinant of macrovascular disease may be an interaction between diabetes and the aging process. Similarly the question of a relationship between macrovascular disease and good metabolic control remains unanswered. Macroangiopathy in diabetic populations seems to be related to similar predictors and pathological mechanisms operating in the general population. However, after analysis of these common risk factors for macroangiopathy, a diabetes-specific risk remains. Low-density lipoprotein metabolism is markedly disturbed in poorly controlled diabetic patients. This is manifest as a concert of actions which increase formation of foam cells and fatty streaks. The next step in the atherosclerotic process, the formation of fibrous plaques, may be associated with the platelet hyperactivity seen in diabetes. This may promote overshooting of repair mechanisms at the vessel wall. Release of a specific diabetic serum growth factor from the platelets may be responsible for the later stages of fibrous plaque development and the increased atherosclerotic risk in diabetes.
More Related Videos
Related Concept Videos
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
01:30Peripheral Artery Disease I: Introduction
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:22Complications of Diabetes Mellitus
01:27Diabetic Retinopathy
01:22Diabetic Neuropathy